DataMEDS AI, Inc.

NAS:MEDSHealthcareNASDAQ:INDSnasdaq_composite

$2.30−0.22%LiveIn session · ≈ AED 8.43 · Market cap $10.31M

MEDS · Cash flow · TradingHolo

USD millions	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Net income	(0.0)	(2.9)	(6.9)	(101.3)	—	—
Depreciation & amortization	0.0	0.0	1.1	0.2	2.3	+1106.4%
Stock-based compensation	0.0	0.0	1.1	54.8	28.6	−47.7%
Change in working capital	0.0	2.5	3.3	8.5	—	—
Operating cash flow	0.0	(0.3)	(1.2)	(10.9)	(13.7)	−26.5%
Capital expenditure	0.0	0.0	(0.4)	0.0	(0.9)	—
Acquisitions	0.0	0.0	0.9	0.0	—	—
Investing cash flow	0.0	0.0	0.5	(0.9)	—	—
Dividends paid	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	0.0	0.0	0.0	0.0	—	—
Debt issued / repaid	0.0	0.4	0.6	(2.1)	—	—
Financing cash flow	0.0	0.4	1.8	10.8	—	—
Free cash flow	0.0	(0.3)	(1.6)	(10.9)	(13.9)	−28.4%
Net change in cash	0.0	0.0	1.0	(1.0)	—	—

USD millionsUpdated Mon 17 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.